Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.5362 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.50205 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5272 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.49306 | 23 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.48481 | 23 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.542 | 20 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.5554 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.97727 | 43 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.02244 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.52196 | 23 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.50742 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.48633 | 22 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.51514 | 22 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49997 | 21 |